328.70M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Intervacc AB (publ), a biotechnology company, engages in the research and development of vaccines for bacterial infections in animal health care. The company devlops vaccines for horses, piglets, and dairy cows. It offers Strangvac, a vaccine for equine strangles.

Similar securities

Based on sector and market capitalization

Report issue